SCHEMBL7278089

SCHEMBL7278089

CC(C)[C@H](N)C(=O)N(C(=O)N(C)Cc1ccccn1)C(Cc1ccccc1)C(O)C(Cc1ccccc1)N(C(=O)[C@@H](N)C(C)C)C(=O)N(C)Cc1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.53
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTPRA P18433 1/20 0.41
HPGD P15428 1/20 0.39
MAOB P27338 1/20 0.39
LMNA P02545 1/20 0.39
AGTR2 P50052 2/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9741338 0.99 CA2 (0.52) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL4440493 0.99 CA2 (0.52) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL6449591 0.99 CA2 (0.52) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL6448970 0.99 CA2 (0.52) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL7270433 0.82 TSHR (0.56) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL7269409 0.82 CYP1A2 (0.45) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL7275895 0.82 PGR (0.47) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL6449597 0.82 CYP1A2 (0.44) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL6447678 0.81 PGR (0.46) CA2CYP1A2CYP2D6MAPTTSHR
SCHEMBL6445021 0.81 PGR (0.46) CA2CYP1A2CYP2D6MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed